CAS: 2435-53-2; 3,4,5,6-Tetrachlorocyclohexa-3,5-Diene-1,2-Dione

相似化合物

3383-21-9 2435-54-3 80284-14-6

上下游产品

CAS号87-86-5 五氯苯酚 | CAS号1198-55-6 四氯邻苯二酚 | CAS号7134-09-0 4-sulf°Catechol | CAS号77796-31-7 4,5,6,7-tetrach... | CAS号77796-32-8 4,5,6,7-tetrach... | CAS号329206-42-0 5-styryl-1,3,4-... | CAS号120-80-9 邻苯二酚 | CAS号944-61-6 四氯藜芦醚 | CAS号86780-29-2 4,5,6,7-tetrach... | CAS号77796-30-6 4,5,6,7-tetrach... | CAS号91821-49-7 4,5,6,7-tetrach... | CAS号620-83-7 4-甲基二苯甲烷 | CAS号713-36-0 2-甲基二苯甲烷 | CAS号7338-94-5 1,3-二苯基丙-2-炔-1-酮 | CAS号21210-43-5 (S)-(+)-扁桃酸甲酯 | CAS号20698-91-3 D-(-)-扁桃酸甲酯 | CAS号87-88-7 氯醌酸 | CAS号1198-55-6 四氯邻苯二酚 | CAS号4141-50-8 Phosphine oxide...

五氯酚 以42%的收率获得邻四氯苯醌
参考文献:Nakano,Hidenori; Tahara,Satoshi; Iizuka,Toshihiko,Agricultural And Biological Chemistry,1987,Vol. 51,# 2,P. 549-556
标题:Nakano,Hidenori; Tahara,Satoshi; Iizuka,Toshihiko,Agricultural And Biological Chemistry,1987,Vol. 51,# 2,P. 549-556

专利信息

专利号:US-8084569-B2
优先权日:2006-12-21
标 题 :Process for the synthesis of diaminopyridines from glutarimidines
发明人：MINTER AARON; STOKES BERLIN
权利人:MINTER AARON; STOKES BERLIN; DU PONT
摘要:A liquid-phase process is provided for the synthesis from glutarimidines of diaminopyridines and related compounds, which are used industrially as compounds and as components in the synthesis of a variety of useful materials. The synthesis proceeds by means of a dehydrogenative aromatization process.

专利号:US-6423877-B1
优先权日:1999-11-15
标题:Synthesis of pseudopterosin compounds
发明人：COREY ELIAS J
权利人:HARVARD COLLEGE
摘要:The present invention is directed to a new synthetic route to pseudopterosin aglycone (3): n a key intermediate for the synthesis of a group of antiinflammatory natural products including pseudopterosin A (1) and E (2). The pathway of synthesis starts with the abundant and inexpensive (S)-(−)-limonene and its long-known cyclic hydroboration product (4) and leads to the chiral hydroxy ketone (6). Conversion of (6) to (10) followed by a novel aromatic annulation produced (15) which underwent highly diastereoselective cyclization to afford the protected pseudopterosin aglycone (16). The naturally occurring pseudopterosins such as (1) and (2) are readily available from this key intermediate.

专利号:US-5932726-A
优先权日:1996-12-16
标 题 :Asymmetric synthesis of benzoxazinones
发明人：PIERCE MICHAEL ERNEST; CHOUDHURY ANUSUYA; PARSONS JR RODNEY LAWRENCE; RADESCA LILIAN ALICIA
权利人:DU PONT PHARM CO
摘要:The present invention provides novel methods for the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (VI-i) ##STR1## which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.

专利号:US-6040480-A
优先权日:1997-04-07
标题 :Asymmetric synthesis of benzoxazinones
发明人：PIERCE MICHAEL E; CHEN CHENG Y; CHOUDHURY ANUSUYA; RADESCA LILIAN A; TAN LUSHI; ZHAO DALIAN
权利人:DU PONT PHARM CO
摘要:The present invention provides novel methods for the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (VI-i) which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.

专利号:US-5126456-A
优先权日:1991-10-17
标题:7-chloroquinaldine synthesis
发明人：SONG ZHIGUO; HUGHES DAVID L
权利人:MERCK & CO INC
摘要:An improved process is described which utilizes tetrachloro-1,4(or 1,2)-quinone as an oxidant in the Doebner-Miller synthesis of 7-chloroquinaldine, a starting material in the preparation of leukotriene antagonists. The process improves yield and eliminates the need of forming a ZnCl 2 complex to isolate the end product.

专利号:US-2024425890-A1
优先权日:2022-02-11
标 题:Process for the synthesis of alpha-methylene-gamma-butyrolactone
发明人：TADEN ANDREAS; BECK HORST; MYRTOLLARI KAMELA; KOURIST ROBERT; NIGL ANDREA
权利人:HENKEL AG & CO KGAA
摘要:The present application provides a process for the preparation of α-methylene-γ-butyrolactone, said process comprising the steps of:a) acetylating the C1-hydroxyl group of isoprenol to yield isoprenyl acetate;b) forming 4-acetoxy-2-methylene-butan-1-ol from said isoprenyl acetate by whole cell biotransformation, said step comprising:i) contacting a cell (CB) with a culture medium containing said isoprenyl acetate or with a culture medium contiguous with an organic phase containing said isoprenyl acetate under conditions that enable the cell to form 4-acetoxy-2-methylene-butan-1-ol from isoprenyl acetate; and,ii) optionally isolating the resultant 4-acetoxy-2-methylene-butan-1-ol, wherein said cell (CB) exhibits activity of at least one alkane monooxygenase enzyme which catalyzes the formation of 4-acetoxy-2-methylene-butan-1-ol from isoprenyl acetate;c) oxidizing said 4-acetoxy-2-methylene-butan-1-ol to yield 4-acetoxy-2-methylene butyric acid; and,d) converting said 4-acetoxy-2-methylene butyric acid to α-methylene-γ-butyrolactone by hydroxylysis to γ-hydroxy-α-methylenebutyric acid and subsequent cyclization of said γ-hydroxy-α-methylenebutyric acid.